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Background: Perivascular adipose tissue (PVAT) exerts anti-contractile effects on
visceral arteries by release of various perivascular relaxing factors (PVRFs) and opening
voltage-gated K+ (Kv) channels in vascular smooth muscle cells (VSMCs). Palmitic acid
methyl ester (PAME) has been proposed as transferable PVRF in rat aorta. Here, we
studied PVAT regulation of arterial tone of human mesenteric arteries and clarified the
contribution of Kv channels and PAME in the effects.
Methods: Wire myography was used to measure vasocontractions of mesenteric
artery rings from patients undergoing abdominal surgery. Isolated aortic rings from
Sprague-Dawley rats were studied for comparison. PVATwas either left intact or removed
from the arterial rings. Vasocontractions were induced by external high K+ (60mM),
serotonin (5-HT) or phenylephrine. PAME (10 nM−3µM) was used as vasodilator. Kv
channels were blocked by XE991, a Kv7 (KCNQ) channel inhibitor, or by 4-aminopyridine,
a non-specific Kv channel inhibitor. PAME was measured in bathing solutions incubated
with rat peri-aortic or human visceral adipose tissue.
Results: We found that PVAT displayed anti-contractile effects in both human
mesenteric arteries and rat aortas. The anti-contractile effects were inhibited by XE991
(30µM). PAME (EC50 ∼1.4µM) was capable to produce relaxations of PVAT-removed
rat aortas. These effects were abolished by XE991 (30µM), but not 4-aminopyridine
(2mM) or NDGA (10µM), a lipoxygenases inhibitor. The cytochrome P450 epoxygenase
inhibitor 17-octadecynoic acid (ODYA 10µM) and the soluble epoxide hydrolase
inhibitor 12-(3-adamantan-1-ylureido)-dodecanoic acid (AUDA 10µM) slightly
decreased PAME relaxations. PAME up to 10µM failed to induce relaxations of
PVAT-removed human mesenteric arteries. 5-HT induced endogenous PAME release
from rat peri-aortic adipose tissue, but not from human visceral adipose tissue.
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Conclusions: Our data also suggest that Kv7 channels are involved in the anti-
contractile effects of PVAT on arterial tone in both rat aorta and human mesenteric
arteries. PAME could contribute to PVAT relaxations by activating Kv7 channels in rat
aorta, but not in human mesenteric arteries.
Keywords: XE991, adipocyte-derived relaxing factor (ADRF), perivascular adipose tissue (PVAT), KCNQ channels,
Kv channels
INTRODUCTION
Perivascular adipose tissue (PVAT), which surrounds the aorta,
its vascular branches and many other arteries, is now recognized
as dynamic paracrine organ and important metabolic sensor
(Szasz et al., 2013; Gil-Ortega et al., 2015; Gollasch, 2017).
PVAT does not only provide mechanical protection to vessels
but also regulates vascular function by releasing perivascular
adipose relaxing factors (PVRFs), particularly a transferable
adipocyte-derived relaxing factor (ADRF), which diminishes the
contractile actions of vasoconstrictors such as phenylephrine
(PE), serotonin (5-HT), angiotensin II and U46619 (Löhn et al.,
2002; Yiannikouris et al., 2010). The anti-contractile effect of
PVAT has been observed in both large and small arteries of
rats, mice, pigs and humans (Bunker and Laughlin, 1985; Szasz
and Webb, 2012; Gollasch, 2017). The anti-contractile effects of
PVAT rely on the opening of K+ channels in vascular smooth
muscle cells (VSMCs) (Tano et al., 2014). This action occurs
without involvement of NO, prostaglandin I2 (prostacyclin) or
endothelium-derived hyperpolarizing factor (EDHF) (Löhn et al.,
2002; Li et al., 2013).
VSMC Kv7 channels are considered to play a key role for
vasodilation by ADRF released from PVAT (Gollasch, 2017).
Consistently, the anti-contractile effects of PVAT are abolished
by the Kv7 channel blocker XE991 in rat and mouse visceral
arteries (Löhn et al., 2002; Schleifenbaum et al., 2010; Tsvetkov
et al., 2016b). Although, the exact nature of ADRF is unknown,
adiponectin, Ang 1–7, H2S and palmitic acid methyl ester
(PAME) have been proposed as ADRF candidates (Fang et al.,
2009; Lee et al., 2011; Gu and Xu, 2013; Lynch et al., 2013).
The effects of adiponectin on vascular tone are mediated by
activation of calcium-activated K+ (BKCa) channels on VSMCs
and adipocytes and by endothelial mechanisms (Lynch et al.,
2013; Baylie et al., 2017), or Kv channel-dependent mechanisms
(Fésüs et al., 2007). PAME is one of the most abundant fatty
acids in mammalian cells (Lau et al., 2017), and represents an
endogenous naturally occurring fatty acid methyl ester (Fukuda
et al., 1967). This compound has been reported to have the ability
to inhibit Kupffer cells which are resident macrophages in the
liver regulating inflammatory processes by secretion of TNF-
alpha and NO (Cai et al., 2005). PAME is also known to exhibit
anti-fibrotic effects (Fukunishi et al., 2011) and to act as potent
vasodilator released in retina and myometrium (Lee et al., 2010,
2011; Crankshaw et al., 2014). A recent report identified PAME as
novel, potent vasodilator released from PVAT in rat aorta, which
exhibits vascular relaxation by opening Kv channels in smooth
muscle cells (Lee et al., 2011). Although these findings suggest
that PAME could represent a potential mediator in control of
vasotonus and blood pressure in rats, the role of Kv7 channels
in PVAT regulation of human arterial tone and vasodilatory
PAME effects remains to be established. Therefore, we tested the
hypothesis that XE991-sensitive Kv (Kv7) channels are involved
in the anti-contractile effects of PVAT on human mesenteric
arteries. Furthermore, we investigated the contribution of
endogenous PAME to PVAT regulation of arterial tone in human
mesenteric arteries and the role of Kv7 channels in vasodilatory
PAME effects. Isolated aortic rings from Sprague-Dawley rats
were studied for comparison. Finally, we tested whether PAME
might contribute to PVAT regulation of arterial tone by involving
metabolism of endogenous lipid epoxides.
MATERIALS AND METHODS
Isometric Contractions of Rat Vessels
The local animal review board of Berlin (LAGESO) approved
all studies, according to American Physiological Society criteria.
Male Sprague-Dawley rats (200–300 g, 8–10 weeks; Charles River,
Sulzfeld/Berlin Germany) were killed, and the thoracic aortas
were removed, and quickly transferred to cold (4◦C) oxygenated
(95%O2/5%CO2) physiological salt solution (PSS), and dissected
into 2mm rings, respectively. Perivascular fat and connective
tissue were either removed [(–) fat] or left [(+) fat] intact
as previously described. The rings were placed under force
of 20 mN. The bath solution volume was 20mL of a vessel
myograph (Schuler tissue bath system, Hugo Sachs Elektronik,
Freiburg, Germany). After 1 h equilibration, contractile force
was measured isometrically using standard bath procedures and
solutions as described (Dubrovska et al., 2004; Kohn et al., 2012;
Brennan et al., 2016).
Cumulative concentration response curves were obtained
for PAME (Löhn et al., 2002) in the presence and absence
of the K+ channel or enzyme inhibitors, 10,10-bis(4-
pyridinylmethyl)-9(10H)-anthracenone dihydrochloride
(XE991); 4-aminopyridine (4-AP); nordihydroguaiaretic
acid (NDGA); 17-octadecadiynoic acid (ODYA); or 12-(3-
adamantan-1-ylureido)-dodecanoic acid (AUDA). Tension was
expressed as a percentage of the steady-state tension (100%)
obtained with isotonic external 60mM KCl. To test for the
presence of functional endothelium, rings were contracted
with 1µM PE and once the vessels reached a stable maximum
tension, the vessels were stimulated with 10µM acetylcholine
(ACh) and relaxation was confirmed (>80%) (Löhn et al.,
2002). In some rings, the endothelium was removed by gently
abrading the luminal surface of the vessel with a stainless steel
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pin to determine the contribution of the endothelium to PAME
relaxation. Functional endothelium was considered absent if
10µMACh did not produce relaxation (Löhn et al., 2002).
In bioassay experiments, we transferred aliquots of bath
solution from aorta with PVAT incubated in a donor bath
chamber to vessel preparations without PVAT in an acceptor
bath chamber of the Schuler tissue bath system (Hugo Sachs
Elektronik, Freiburg, Germany). Cumulative response curves
were obtained in the presence and absence of 5-HT (total
incubation time, 5min). The volume of the solutions in the bath
was 20mL. In most experiments, transfer interval of aliquots was
15–20min; the volume of the aliquots was 3 or 5mL. Transfer
of bath solution aliquots from aortic vessels without PVAT or
fresh PSS did not affect contraction of vessel preparations without
PVAT in the acceptor bath chamber (Löhn et al., 2002).
Isometric Contractions of Human Vessels
Procedures were performed in accordance with the ethics
guidelines of the National Health and Medical Research Council
of Germany. All patients provided informed consent for
participation in this study. Mesenteric tissue was taken from
12 patients (1 female, 11 males) undergoing surgical treatment
of bowel carcinoma or inflammatory bowel disorders [colon
cancer (n = 3), sigma cancer (n = 4), rectal cancer (n =
1), colon adenoma (n = 1), Crohn’s disease (n = 1), and
sigmoid diverticulitis (n = 1)]. The mean age of the patients
was 69 years (range: 46–80), the mean BMI of the patients was
25 kg/m2 (range: 20–30 kg/m2), which is expected for the general
population, since adopting the WHO classification is that ∼50%
or more of the general adult population will always be in the
overweight range (now pre-obese, BMI 25–30 kg/m2), at least
in the US and Western Europe (Nuttall, 2015). Few patients
were taking drugs, including β-blockers (n = 4), angiotensin-
converting-enzyme inhibitors (n = 2), metformin (n = 2),
calcium channel blocker (n = 1), diuretic (n = 1), or fibrates
(n = 1). Immediately after lower intestinal surgery, mesenteric
arteries were excised from resected mesenteric tissue, and quickly
transferred to cold (4◦C) oxygenated (95% O2/5% CO2) PSS, and
dissected into 1mm rings. PVAT was either removed [(−) fat]
or left [(+) fat] intact as previously described (Schleifenbaum
et al., 2014). Each ring was positioned between two stainless
steel wires in a 5-mL organ bath of a Small Vessel Myograph
(DMT 610M; Danish Myo Technology, Denmark) (Tsvetkov
et al., 2016a). The organ bath was filled with PSS. The bath
solution was continuously oxygenated with a gas mixture of 95%
O2 and 5%CO2, and kept at 37
◦C (pH 7.4). The rings were placed
under force of 3 mN. The software Chart5 (AD Instruments Ltd.
Spechbach, Germany) was used for data acquisition and display.
The rings were pre-contracted with 60mM KCl and equilibrated
until a stable resting tension was acquired. Chemicals were added
to the bath solution if not indicated otherwise. Vessels were pre-
contracted with either 5-HT or phenylephrine. All chemicals
were added to the bath solution (PSS).
Gas Chromatography/Mass Spectrometry
(GC/MS) Analysis
PAME measurements were performed by Shanghai Ingeer
Certification Assessment Co, Ltd (ICAS, Shanghai, China).
GC/MS analysis was performed using an Agilent ChemStation.
For determination of endogenous PAME concentrations in bath
solutions, rat peri-aortic and human visceral adipose tissue (3 g
each) were incubated in 15 mL-Eppendorf tubes with 10mL
PSS solutions, with or without 5-HT 5µM (30min, in 37◦C
water bath). PSS was oxygenated (95% O2/5% CO2) for 30min
before use. After removal of adipose tissue, the PSS solution were
dissolved in hexane (1:3 volume ratio), extracted and vortexed.
Next, 1mL water was added to the solution. In order to ensure
that the concentration of PAME between the aqueous and the
lipophilic phase was in equilibrium the samples were shaken
by hand for 4min. Thereafter, the phases were separated by
centrifugation and the lipophilic hexane phase containing fatty
acid methyl esters was removed and dried under nitrogen. The
fatty acidmethyl ester residues were re-dissolved in 50µL hexane
and transferred into an autosampler vial. Samples were analyzed
by using a fully automatedAgilent 7890A-5977B system equipped
with a flame ionization detector. Peaks of re-dissolved PAME
were identified by comparison with PAME standard and their
nominal concentrations were determined (Yi et al., 2014; Siegert
et al., 2017). (+) Fat masses were measured in rat aortic (2mm)
and human mesenteric artery (1mm) rings (n = 6 each) to
calculate magnitudes of effective [PAME] in the 20 or 5mL
myograph bath chambers, respectively.
Materials and Statistics
The composition of PSS (in mM) was 119 NaCl, 4.7 KCl,
1.2 KH2PO4, 25 NaHCO3, 1.2 MgSO4, 11.1 glucose, and 1.6
CaCl2. The composition of 60mM KCl solution (in mM) was
59 NaCl, 60 KCl, 1.2 KH2PO4, 25 NaHCO3, 1.2 MgSO4, 11.1
glucose, and 1.6 CaCl2. All salts were purchased from Sigma
Aldrich (Schnelldorf, Germany). XE991 was purchased from
Tocris (Bristol, UK). 5-HT, phenylephrine (PE), 4-aminopyridine
(4-AP), nordihydroguaiaretic acid (NDGA), 17-octadecynoic
acid (ODYA), 12-(3-adamantan-1-ylureido)-dodecanoic acid
(AUDA) were purchased from Sigma Aldrich (Schnelldorf,
Germany). PAME were purchased from Cayman Chemical (Ann
Arbor, Michigan, USA).
Data were analyzed by Prism version 5.0 (GraphPad Software,
La Jolla, California, USA) and were shown as mean ± SD or
mean ± SEM. Paired, unpaired Student’s t-tests or one-way
ANOVA were used as appropriate. In Figures 1C, 2C, statistical
significance was determined by two-way ANOVA or repeated-
measures two-way ANOVA, followed by Bonferroni post-hoc
test, and using Prism 6 software. A value of P < 0.05 was
considered statistically significant; n represents the number of
arteries tested.
RESULTS
Contraction of Rat Aortas and Human
Mesenteric Arteries With and Without PVAT
Under Kv7 Channel Inhibition
We first investigated the role of Kv7 channels in the anti-
contractile effects of PVAT in rat aortas. Rat aortic rings without
PVAT [(–) fat] showed stronger contractions to 5-HT (relative
increase, 60–100% between 2 and 10µM 5-HT) than vessels
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FIGURE 1 | Presence of anti-contractile effects of perivascular adipose tissue
(PVAT) in rat aorta and their inhibition by XE991. (A,B) Original recordings
showing inhibition of the anti-contractile effects of PVAT by XE991. Incubation
of (–) fat aortic rings with 30µM XE-991 (A) had no effect on the contractile
response. Incubation of (+) fat aortic rings with 30µM XE991 (B) increased
the contractile response to 5-HT. (C) Concentration-response curves for 5-HT
(1–10µM) in (+) fat vessels in the presence (n = 6) and absence of XE991 (n =
6) and in (–) fat vessels in the presence (n = 12) and absence of XE991 (n = 6).
*p < 0.05 for (+) fat control vessels compared to all other groups each, 60
KCl, 60mM KCl.
with PVAT [(+) fat] (Figure 1). Incubation of the vessels with
the Kv7 channel inhibitor XE991 (30µM, 30min) inhibited the
anti-contractile effects of PVAT mediated by transferable ADRF
in rat aortic rings (Figures 1B,C, Supplementary Figures 1).
XE991 slightly (<20%) increased contractions of (–) fat rat aortic
rings in response to 5-HT, but there was no difference between
contractions of (–) fat and (+) fat rings in response to 5-HT
(Figures 1A,C). Contraction of (–) fat and (+) fat aortic rings
obtained by 60mM KCl containing PSS were not different (13.07
± 1.29 mN, n = 16 vs. 10.81 ± 1.19 mN, n = 14, P > 0.05,
respectively).
Similar results were observed in human visceral arteries.
Human mesenteric arteries without PVAT [(−) fat] showed
significantly stronger contractions in response to 5-HT than
vessels with PVAT [(+) fat] (Figure 2). Incubation of the
vessel rings with XE991 (30µM, 30min) inhibited the anti-
contractile effects of PVAT (Figures 2B,C). XE991 did not affect
FIGURE 2 | Presence of anti-contractile effects of PVAT in human mesenteric
arteries and their inhibition by XE991. (A,B) Original recordings showing
inhibition of the anti-contractile effects of PVAT by XE991 (30µM). Recordings
are shown in the presence (red curves) and absence (black curves) of XE991.
XE991 had no effects on 5-HT contractions in (–) fat rings (A), but increased
5-HT contractions in (+) fat rings (B). (C) Concentration-response curves for
5-HT (0.01–100µM) in (+) fat vessels in the presence (n = 13) and absence of
XE991 (n = 15) and in (–) fat vessels in the presence (n = 10) and absence of
XE991 (n = 10). *p < 0.05, p < 0.05 for (+) fat control vessels compared to all
other groups each.
5-HT-induced contractions in (–) fat human mesenteric artery
rings (Figures 2A,C).
Similar data were obtained when vessels were contracted with
phenylephrine (Supplementary Figures 2). These data suggest
that PVAT displays anti-contractile effects in both rat aortas
and human mesenteric arteries mediated by XE991-sensitive
Kv7 channels, and occur independently of the vasoconstrictor
agonists used, i.e., serotoninergic or alpha-adrenergic agonists.
Contraction of (–) fat and (+) fat humanmesenteric arterial rings
obtained by 60mM KCl containing PSS were not different (19.46
± 3.60 mN, n = 10 vs. 21.00 ± 2.15 mN, n = 12, P > 0.05,
respectively).
PAME Relaxations and Effects of NDGA,
ODYA, and AUDA
Exogenous PAME (EC50 ∼1.4µM; maximal relaxation Emax
∼25%) was capable of producing relaxations of (–) fat rat aortas
(Figure 3). PAME relaxations were not affected by removal
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of the endothelium (Figure 3C). Pre-treatment of aortic rings
with XE991 (30µM, 30min) prevented the relaxant effects
of PAME (Figures 3B,F). PAME effects were not abolished
by the Kv channel blocker 4-aminopyridine (4-AP 2mM,
10min) (Figure 3D) or NDGA (10µM, 30min), a lipoxygenases
inhibitor (Figure 3G). The cytochrome P450 epoxygenase
inhibitor 17-octadecynoic acid (ODYA 10µM, 30min) slightly
inhibited PAME relaxations in rat aorta (Figure 3E). However,
the soluble epoxide hydrolase inhibitor 12-(3-adamantan-1-
ylureido)-dodecanoic acid (AUDA 10µM, 30min) did not
increase PAME relaxations (Figure 3H), which is expected for
involvement of P450 expoygenase mediators. Instead, it inhibited
PAME relaxations implicating non-specific effects of ODYA in
inhibiting PAME effects. PAME up to 10µM failed to induce
relaxations of (–) fat human mesenteric arteries (Figure 4).
Pre-treatment of the vessels with XE991 (30µM, 30min) did
not affect the lack of PAME effects (Figures 4B,C). Taken
together, the results indicate that exogenous PAME at relatively
high concentrations (EC50 >1µM) can induce slight (Emax
∼25%) relaxations in pre-contracted rat aortic rings, which are
mediated by opening of Kv7 channels. In contrast, PAME is
not a potent vasodilator (up to 10µM) of human mesenteric
arteries.
Role of PAME in ADRF-Containing Bath
Solutions of Rat Aortas and Contribution of
Kv7 Channels
To demonstrate that the intact aortic preparation releases ADRF
which can abrogate vascular contraction by opening VSMC
Kv7 channels (Tano et al., 2014; Gollasch, 2017), we performed
bioassay experiments where we transferred aliquots of the bath
solution from an intact donor preparation incubated in 2µM
5-HT-containing solution to vessel preparations without PVAT,
pre-contracted with 5-HT. This maneuver transferred the factor
(Tano et al., 2014; Gollasch, 2017) released by either intact
preparations or isolated perivascular adipose tissue (PVAT)
(Figure 5B) to arteries without adipose tissue (Tano et al., 2014).
Bath solutions from (+) fat rings incubated with 5-HT produced
stronger relaxations than bath solutions from (+) fat rings
incubated in PSS without 5-HT (Figures 5A right, B), indicating
that ADRF release is increased by 5-HT. According to the
proposed Kv7 channel mechanism (Tano et al., 2014; Gollasch,
2017), ADRF produced relaxations, which were inhibited by
XE991 (30µM) (Supplementary Figures 1). Next, we were
interested in [PAME] in ADRF-containing bath solutions and
whether PAME release from PVAT can be stimulated by 5µM
5-HT. We found that 5-HT is capable to release endogenous
FIGURE 3 | Effects of palmitic acid methyl ester (PAME, 0.01–10µM) on rat aorta. The effects are shown in the absence (control, black curves) and presence (red
curves) of inhibitors of Kv channels [4-aminopiridine (4-AP) 2mM] or XE991 30µM, lipoxygenase (LOX 15,12,5) (nordihydroguaiaretic acid (NDGA) 10µM),
cytochrome P450 (CYP) [17-octadecynoic acid (17-ODYA) 10µM], and soluble epoxide hydrolase (sEH) [12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA)
10µM]. The effects were studied in the presence (+) and absence (–) of endothelium in 2µM 5-HT precontracted (–) fat aortic rings. (A,B) Original recordings
demonstrating the relaxant effect of PAME (0.01–10µM) and inhibition of this effect (B) by pre-treatment of the vessels with 30µM XE991.
(C) Concentration-response curves for PAME in (–) fat aortic rings in the presence (Control) (n = 8) and absence (–) of the endothelium (n = 6).
(D) Concentration-response curves for PAME in the absence (n = 13) and presence (n = 7) of 2mM 4-AP in (–) fat aortic rings. (E) Concentration-response curves for
PAME in non-treated (n = 13) and 10µM 17-ODYA treated (n = 6) (–) fat aortic rings. *p < 0.05. (F) Concentration-response curves for PAME in the absence (n = 6)
and presence (n = 6) of 30µM XE991 in (–) fat aortic rings. *p < 0.05. (G) Concentration-response curves for PAME in non-treated (n = 13) and 10µM NDGA (n = 6)
treated (–) fat aortic rings. (H) Concentration-response curves for PAME in non-treated (n = 13) and 10µM AUDA treated (n = 6) (–) fat aortic rings. Data are
expressed as mean ± SEM. *p < 0.05.
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FIGURE 4 | Lack of palmitic acid methyl ester (PAME, 0.01–10µM) to induce relaxation in human mesenteric artery rings and measurements of PAME in bath
solutions from human (+) fat mesenteric artery rings. (A,B) Original recordings demonstrating lack of vasorelaxant effects of PAME (0.01–3µM) in (–) fat rings. Effects
of PAME are shown in the absence (control, black curves) and presence (red curves) of XE991. The effects were studied on 2µM 5-HT pre-contracted (–) fat
mesenteric artery rings. (C) Concentration-response curves for PAME in (–) fat rings in the presence (Control) (PAME 0.01–3µM, n = 12; PAME 10µM, n = 8) and
absence (PAME 0.01–3µM, n = 12; PAME 10µM, n = 8) of XE991. (D) Production of PAME shows no difference between bath solutions from human visceral
adipose tissue incubated in the presence (n = 8) and absence of 5-HT (n = 8). w/o, without; n.s., not significant.
PAME from rat aortic PVAT samples (Figure 5C). However, the
PAME concentrations in 10mL PSS solutions containing 3 g
rat aortic PVAT samples were lower than 300 nM, indicating
that effective PAME concentrations in myograph bath chambers
are in the range of <1 nM (i.e., 500 times lower). Figures 5C,
3A–H show that [PAME] lower than 1 nM are unable to affect
wall tension to produce relaxations of (–) rat aortas. These
data indicate that PAME cannot be the transferable ADRF
we seek.
Endogenously Released PAME Levels in
Bath Solutions of Human Visceral Adipose
Tissue Are Low and Not Controlled by 5-HT
Endogenously released nominal PAME levels were also detected
in aliquots of bath-solutions containing 3 g human visceral
adipose tissue in 10mL PSS (Figure 4D). However, in contrast
to the rat aorta (Figure 5C), PAME levels were even lower and
5-HT (5µM) was unable to induce endogenous PAME release
in the adipose tissue samples. These data indicate that 5-HT can
induce PAME release from rat peri-aortic adipose tissue, but not
from human visceral adipose tissue, where spontaneous PAME
release is even lower and not controlled by 5-HT.
DISCUSSION
In the present study, we investigated the roles of Kv7 channels
and PAME in PVAT regulation of arterial tone in human visceral
mesenteric arteries. The major findings are that XE991-sensitive
Kv (Kv7) channels are involved in the anti-contractile effects
of PVAT on human mesenteric arteries, similarly to rat aortas.
Furthermore, exogenous PAME displays properties of a PVRF in
rat aorta, where it may contribute to paracrine PVAT regulation
of arterial tone, but not in human mesenteric arteries. Our data
indicate that PAME is not ADRF. Nevertheless, the data support
previous findings (Lee et al., 2011) suggesting that fatty acids,
particularly perivascular adipose tissue-derived methyl palmitate
(PAME), can play a role in paracrine regulation of vascular
tone and possibly in the pathogenesis of hypertension in rats,
where deficiency or malfunction of Kv channels (Gálvez et al.,
2006; Galvez-Prieto et al., 2008), particularly Kv7 channels (Jepps
et al., 2011; Li et al., 2013; Zavaritskaya et al., 2013), have
been suggested to be involved. Our results suggest that these
effects could involve malfunctional Kv7 channels, independently
of metabolism of endogenous lipid epoxides. Since the [PAME]
released into bathmedia were exceptionally low, we conclude that
PAME released from PVAT only in close proximity to VSMCs can
regulate arterial tone in rat aorta.
PVAT Effects and Kv7 Channels
We demonstrated earlier that PVAT markedly attenuates the
contractile response to 5-HT, phenylephrine and angiotensin II in
aortic and mesenteric ring preparations of rats (Löhn et al., 2002;
Verlohren et al., 2004). The data suggest a major role of the Kv7
family of K+ channels as putative downstream targets of ADRF,
which is a major PVRF released from PVAT to reduce arterial
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tone (Zavaritskaya et al., 2013; Gollasch, 2017). This suggestion
is supported by findings showing that XE991 (Kv7 blocker)
inhibited the anti-contractile effects of PVAT in visceral arteries
of rats and mice (Schleifenbaum et al., 2010; Tano et al., 2014)
(this study). Data were obtained by two different vasoconstrictor
agonists, namely 5-HT and phenylephrine, indicating that Kv7
channel targeting could be common mechanism for PVAT
regulation of arterial tone. We employed XE991 at 30 µmol/L
to ensure effective block of the Kv7 channels because native
VSMC Kv7.4 and Kv7.5 channels are inhibited by this compound
with IC50 of 5.5 and 65 µmol/L, respectively (Tykocki et al.,
2017). The XE991 effects are unlikely mediated by inhibition
of BKCa or Kv7.1 channels (Tsvetkov et al., 2016b, 2017). Our
present results show that PVAT displayed anti-contractile effects
in human mesenteric arteries. The anti-contractile effects were
inhibited by XE991, supporting the idea that Kv7 channels are
involved in PVAT regulation of arterial tone in humans. Data
obtained on Kcnq1−/− mice (Tsvetkov et al., 2016b) suggest that
these effects are mediated by Kv7 channels distinct from Kv7.1,
i.e., most likely Kv7.3, Kv7.4 and/or Kv7.5, which are all expressed
in mesenteric artery VSMCs from rats (Mackie et al., 2008; Jepps
et al., 2011; Zavaritskaya et al., 2013), mice (Yeung et al., 2007;
Tsvetkov et al., 2016b, 2017), and humans (Ng et al., 2011).
PAME Effects and Kv7 Channels
We found that PAME was capable to produce relaxations of rat
aortas. These effects were inhibited by XE991. The effects were
not inhibited 2mM 4-AP, but see (Lee et al., 2011). In contrast,
PAME at similar concentrations did not relax human mesenteric
arteries. Together, these data suggest that PAME could contribute
to PVAT relaxations by activating Kv7 channels in rat aorta,
but not in human mesenteric arteries. The results are in line
with the idea that 4-AP is not inhibiting Kv7 channels in rat
aorta. We next explored the role of PAME and Kv7 channels
in the anti-contractile effects of PVAT in rat aorta using a
bioassay approach (Gálvez et al., 2006; Galvez-Prieto et al., 2008).
In these experiments, we confirmed earlier findings indicating
that 5-HT induces vessel relaxation by releasing a transferable
vasoactive substance (ADRF) from PVAT into the bath solution
(Maenhaut and Van de Voorde, 2011; Gollasch, 2012). As a
negative control, we transferred aliquots of periadventitial fat
solution in a similar fashion without 5-HT. We found that these
aliquots produced less potent relaxations in rat aortas without
PVAT suggesting that 5-HT is capable to stimulate the release of
ADRF from PVAT. Moreover, inhibition of Kv7 channels in (–)
fat aortic rings by XE991 disrupted these effects in our bioassay
experiment. We previously demonstrated that ADRF effects
occur without involvement of the endothelium (Gollasch, 2012).
Thus, the present data indicate that 5-HT induces ADRF release
from PVAT, which displays anti-contractile properties though
activation of XE991-sensitive (Kv7) Kv channels in VSMCs.
We next focused on PAME bioactivity and release under these
conditions. This part of our study is important for understanding
the role of PAME as putative ADRF and/or paracrine PVRF. We
found that PAME (EC50 ∼1.4µM) only slightly relaxed rat aortas
(Emax, about 25%), whereas similar concentrations of PAME had
no effects on human mesenteric arteries.
FIGURE 5 | Relaxation of (–) fat aortic rings induced by transfer of bath
solutions from (+) fat rat aortic rings. (A) Original recordings demonstrating
stronger relaxations of ADRF-containing bath solutions from (+) fat rings
incubated with 5-HT than from (+) fat rings incubated in PSS without 5-HT.
(B) Bath solutions from (+) fat rings incubated with 5-HT produced stronger
relaxations than bath solutions from (+) fat rings incubated in PSS without
5-HT. Relaxation is expressed as a percentage of the steady-state tension
(100%) obtained with 2µM 5-HT. Data are expressed as mean ± SEM of 6
(left bar) and 5 rings (right bar) prepared from 6 and 5 animals, respectively.
(C) Bath solutions from rat peri-aortic adipose tissue incubated in the
presence 5-HT (n = 8) produced more PAME than bath solutions from rat
peri-aortic adipose tissue incubated in the absence of 5-HT (n = 8). *p < 0.05.
PAME Source and Metabolism
Palmitic acid, or hexadecanoic acid in IUPAC nomenclature,
is the most common saturated fatty acid found in plants,
animals and humans. Together with stearic acid and oleic acid,
palmitate acid belongs to the free fatty acids (FFAs), which
play an important role as a source of energy for the body
(Ibarguren et al., 2014). Endogenous PAME appears to play a
role in modulation of the autonomic ganglionic transmission
and vasodilatory effects of nitric oxide (NO) (Lin et al., 2008).
In plants, palmitate acid can be metabolized through the
lipoxygenase pathway (Osipova et al., 2010). However, there
is no evidence that palmitate acid is metabolized through
the lipoxygenase pathway in animals or humans. Although
palmitate acid seems to have some effects on lipoxygenase
and cyclooxygenase in platelets (Sakai et al., 1976), there
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are no reports that this occurs in other mammalian cells.
Consistently, it is not surprising that NDGA, a non-selective
lipoxygenase inhibitor, failed to inhibit exogenous PAME
relaxation in rat aorta in our study, suggesting no involvement
of lipoxygenases metabolites in the PAME effects in the
vasculature.
Dietary triacylglycerols with palmitic acid can reduce
plasma phospholipid arachidonic and docosahexaenoic acids
in vivo (Innis and Dyer, 1997). To rule out involvement of
cytochrome P450 (CYP) metabolites in PAME relaxation in
rat aorta, we tested the effects of a CYP epoxygenases and
FFA ω-hydrolases inhibitor (ODYA), and a soluble epoxide
hydrolase inhibitor (AUDA), which blocks breakdown and
inactivation of CYP–derived active vasodilatory metabolites
from arachidonic acid, linoleic acid, eicosapentaenoic acid and
docosahexaenoic acid (Hercule et al., 2007, 2009). Since ODYA
(10µM) and AUDA (10µM) did not produce reciprocal effects
on PAME relaxations, we conclude that PAME is a vasodilator
in rat aorta independently of metabolism of endogenous lipid
epoxides.
PAME Released by PVAT
Most vessels possess some amount and type of PVAT, varying
frommostly brown fat (thoracic aorta) tomixed brown and white
fat (mesenteric vessels) (Watts et al., 2013). We were able to
detect endogenously released PAME in bathing solutions of both
rat peri-aortic and human visceral adipose tissues. Furthermore,
5-HT was capable to induce PAME release from rat peri-
aortic adipose tissue, indicating a humoral active release process.
However, the measured nominal concentrations of PAME were
too low to explain transferable ADRF properties in both vascular
preparations under study. Together, we suggest that PAME is
actively released from PVAT and displays properties of relaxing
factor in rat aorta, but not in human mesenteric arteries, where it
may contribute as paracrine PVRF to PVAT regulation of arterial
tone, independently of metabolism of endogenous lipid epoxides.
It will be interesting to determine human mesenteric PVAT is
unresponsive to PAME release and action because it is mostly
white adipose tissue.
In conclusion, our studies implicate important roles of
Kv7 channels in PVAT control of arterial tone in both rat
aorta and human mesenteric arteries, which supports previous
findings obtained on other, non-human arteries (Gollasch,
2017). Furthermore, our study highlights the potential role
of PAME to contribute as paracrine PVRF to regulation of
vascular contraction by opening Kv7 channels, at least in rats.
Our study has translational implications since malfunction of
PVAT/Kv7 channels has been proposed to contribute and to
serve as therapeutic targets to improve vascular dysfunction in
experimental obesity and hypertension (Rahmouni, 2014), but
data on existence of this prototype of vasoregulation in human
vessels were missing. Further studies are warranted to investigate
PVRFs, Kv7 and other vascular potassium channels to develop
new prevention and treatment strategies for cardiovascular
disorders associated with obesity and hypertension.
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